ClinicalTrials.Veeva

Menu

Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine Learning

The University of Hong Kong (HKU) logo

The University of Hong Kong (HKU)

Status

Unknown

Conditions

Oral Squamous Cell Carcinoma

Treatments

Procedure: Surgery

Study type

Observational

Funder types

Other

Identifiers

NCT04543266
UW19-704

Details and patient eligibility

About

Application Management Team:

PI - Siu Wai Choi; email - htswchoi@hku.hk Delegates - Chui Shan Chu; email: sunshine.c@connect.hku.hk FollowUpUsers - Chui Shan Chu; email:sunshine.c@connect.hku.hk

Full description

Eligibility Criteria:

  • patients were diagnosed with a baseline disease of oral squamous carcinoma.

Exclusion Criteria:

  • N/A

Sample size:

  • ~500 subjects

Source of Data:

  • The data, such as age and medical records, would be obtained from Hospital Authority Clinical Management System (HACMS)

Statistical analysis:

  • machine learning will be applied into analysis plan

Enrollment

500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with oral squamous carcinoma
  • received surgery from 1st October 2000 to 1st October 2019

Exclusion criteria

N/A

Trial design

500 participants in 2 patient groups

Patients with Progressive Disease
Description:
Patients with metastasis and/or recurrent OSCC were considered as a group of subjects with progressive disease
Treatment:
Procedure: Surgery
Patients without Progressive Disease
Description:
Patients without metastasis and/or recurrent OSCC were considered as a group of subjects without progressive disease
Treatment:
Procedure: Surgery

Trial contacts and locations

1

Loading...

Central trial contact

Chui Shan Chu, MMedSc; SW Choi, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems